3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Multiple Myeloma
22
Lymphoma, Large B-Cell, Diffuse
16
Recurrence
7
Neoplasms, Plasma Cell
5
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Acute
4
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, B-Cell
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Paraproteinemias
2
Neoplasms by Histologic Type
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Hematologic Diseases
2
Colorectal Neoplasms
2
Blood Protein Disorders
2
Sezary Syndrome
1
Renal Insufficiency
1
Neuroblastoma
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
fludarabine phosphate
3
Cyclophosphamide
3
Antilymphocyte Serum
3
Rituximab
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methylprednisolone
2
Methotrexate
2
Melphalan
2
Busulfan
2
Weights and Measures
1
Vincristine
1
Thioguanine
1
Tacrolimus
1
Ritonavir
1
Prednisolone
1
Polymerase Chain Reaction
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Indinavir
1
Geriatric Assessment
1
Gelclair
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Dendritic Cell Sarcoma, Interdigitating
×
Lenalidomide
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled